REVUFORJ: payments to doctors
Payments that named REVUFORJ as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.9M
- Providers
- 885
- Transactions
- 2,131
- Average per transaction
- $912
The per-transaction average — $912 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 885 providers the average total is $2,196, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | $1,943,186 | 100.0% |